Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / SPONSORED ADR NE
-
Number of holders
-
4
-
Total 13F shares, excl. options
-
253,058
-
Shares change
-
-5,586
-
Total reported value, excl. options
-
$613,370
-
Value change
-
-$16,662
-
Number of buys
-
2
-
Number of sells
-
-2
-
Price
-
$2.40
Significant Holders of XTL BIOPHARMACEUTICALS LTD - SPONSORED ADR NE (XTLB) as of Q2 2024
5 filings reported holding XTLB - XTL BIOPHARMACEUTICALS LTD - SPONSORED ADR NE as of Q2 2024.
XTL BIOPHARMACEUTICALS LTD - SPONSORED ADR NE (XTLB) has 4 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 253,058 shares
.
Largest 5 shareholders include Noked Israel Ltd (198,888 shares), MORGAN STANLEY (33,151 shares), CITADEL ADVISORS LLC (15,435 shares), RHUMBLINE ADVISERS (5,584 shares), and UBS Group AG (0 shares).
This table shows the top 4 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.